I want to know about...

FRIDAY, JULY 23, 2021

THE CITY RECORD

4693

ARTICLE III
COMMERCIAL DISTRICT REGULATIONS

CITY PLANNING COMMISSION
PUBLIC HEARINGS

In light of the Governors announcement on June 24, 2021, of the end of the State-Declared State of Emergency, and in support of the Citys continued efforts to contain the spread of COVID-19, the City Planning Commission, will hold a public hearing accessible both in person and remotely.
The public hearing will be held on Thursday, July 29, 2021, starting at 10:00 A.M. Eastern Daylight Time. The public hearing will be held in person in the NYC City Planning Commission Hearing Room, Lower Concourse, 120 Broadway, New York, NY. Masks are required to be worn to enter the building and during the hearing.

Chapter 2
Use Regulations

32-30
USES PERMITTED BY SPECIAL PERMIT
32-32
By the City Planning Commission In the districts indicated, the following uses are permitted by special permit of the City Planning Commission, in accordance with standards set forth in Article VII, Chapter 4, or as otherwise indicated in this Section.

C1 C2 C3 C4 C5 C6 C7 C8

The meeting will be live streamed through Department of City Plannings DCPs website and accessible from the following webpage, which contains specific instructions on how to observe and participate remotely, via the teleconferencing application Zoom, as well as materials relating to the meeting: https www1.nyc.gov/site/nycengage/
events/city-planning-commission-special-public-meeting/295196/1.

Railroad passenger stations
Members of the public attending remotely should observe the meeting through DCPs website. Verbal testimony can be provided remotely by joining the meeting using either Zoom, or by calling the following number and entering the information listed below:

C1 C2 C3 C4 C5 C6 C7 C8
Seaplane bases
Administration
253 215 8782 US Toll Number 213 338 8477 US Toll Number Meeting ID: 618 237 7396
Press to skip the Participation ID
Password: 1
Written comments will also be accepted until 11:59 P.M., one week before the date of vote. Such written testimony may be submitted, at the hearing, or through the CPC Comments form that is accessible through the above webpage.
Please inform the Department of City Planning if you need a reasonable accommodation, such as a sign language interpreter, in order to participate in the meeting. The submission of testimony, verbal or written, in a language other than English, will be accepted, and real time interpretation services will be provided based on available resources. Requests for a reasonable accommodation or foreign language assistance during the meeting should be emailed, to AccessibilityInfo@
planning.nyc.gov, or made by calling 212-720-3508. Requests must be submitted at least five business days before the meeting.
BOROUGH OF MANHATTAN
Nos. 1, 2 & 3
NEW YORK BLOOD CENTER
No. 1

CD 8
C 210351 ZMM
IN THE MATTER OF an application submitted by New York Blood Center, Inc., pursuant to Sections 197-c and 201 of the New York City Charter, for an amendment of the Zoning Map, Section No. 8c:

2.

Research and development facility, scientific, in C2-7 Districts within Community District 8 in the Borough of Manhattan, and in C6
Districts
ARTICLE VII

877 853 5247 US Toll-free 888 788 0099 US Toll-free
1.

C2-7 C6

Chapter 4
Special Permits by the City Planning Commission 74-40
USE PERMITS

74-48
Scientific Research and Development Facility In C2-7 Districts within Community District 8 in the Borough of Manhattan, and in C6 Districts, the City Planning Commission may permit a scientific research and development facility containing as a commercial use, where such facility contains laboratories for medical, biotechnological, chemical or genetic research, including space for production, storage and distribution of scientific products generated through research and may modify height and setback regulations for the facility. Such facility shall conform to the performance standards applicable to M1 Districts and occupy a zoning lot that either contains a minimum lot area of 40,000 square feet or comprises an entire block. No residential use is to be located anywhere on a zoning lot containing such a facility, in conjunction with such facility, may allow the modifications set forth in paragraph a of this Section.
For a special permit to be granted, applications shall comply with conditions in paragraph b and the findings of paragraph c of this Section. Additional requirements are set forth in paragraph d.
a.

Additional modifications For such scientific research and development facility, the Commission may modify the following:

changing from an R8B District to a C2-7 District property, bounded by East 67th Street, a line 325 feet easterly of Second Avenue, East 66th Street and a line 100 feet easterly of Second Avenue; and changing from a C1-9 District to a C2-8 District property, bounded by East 67th Street, a line 100 feet easterly of Second Avenue, East 66th Street, Second Avenue, East 66th Street, and a line 100 feet westerly of Second Avenue;

1.

height and setback regulations; and
2.

where such facility is located within C2-7 Districts:

as shown on a diagram for illustrative purposes only, dated April 19, 2021, and subject to the conditions of CEQR Declaration E-612.
No. 2

CD 8
N 210352 ZRM
IN THE MATTER OF an application submitted by New York Blood Center, Inc., pursuant to Section 201 of the New York City Charter, for an amendment of the Zoning Resolution of the City of New York, modifying Article VII, Chapter 4, for the purpose of allowing scientific research and development facilities in C2-7 Districts and allowing related use and bulk modifications, and modifying APPENDIX F, for the purpose of establishing a Mandatory Inclusionary Housing area.
Matter underlined is new, to be added;
Matter struck out is to be deleted;
Matter within is defined in Section 12-10;
indicates where unchanged text appears in the Zoning Resolution.

i.

sign regulations;

ii.

floor area ratio regulations, up to the maximum floor area ratio permitted for community facility uses for the District; and
iii. yard regulations.
b.

Conditions As a condition for granting a special permit, such facility shall:

c.

1.

conform to the performance standards applicable to M1
Districts;

2.

occupy a zoning lot that either contains a minimum lot area of 40,000 square feetor comprises an entire block; and
3.

occupy a zoning lot containing no residential use.

Findings
As a condition for granting a special permit, the Commission shall find that the scientific research and development facility: